Dispute settlement understanding on the use of Botox in chronic migraine.
Paolo
P
Martelletti
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D020773:Headache Disorders / Q000145:classification* / Q000188:drug therapy*; D006801:Humans; D008881:Migraine Disorders / Q000145:classification / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
J Headache Pain. 2009 Dec;10(6):395-406
19795182
Neuropsychiatr Dis Treat. 2010 Apr 07;6:81-91
20396640
J Headache Pain. 2011 Feb;12(1):5-12
20878535
Curr Neurol Neurosci Rep. 2010 Mar;10(2):140-6
20425239
Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):39-47
21142809
J Headache Pain. 2010 Apr;11(2):151-6
20213484
J Headache Pain. 2006 Oct;7(5):317-9
17058036
J Headache Pain. 2009 Dec;10(6):407-17
19802522
Intern Emerg Med. 2011 Feb;6(1):23-8
20496013
J Headache Pain. 2010 Oct;11(5):431-5
20652353
Curr Pain Headache Rep. 2011 Feb;15(1):4-7
20882371
J Headache Pain. 2006 Dec;7(6):407-12
17149565
J Headache Pain. 2009 Apr;10(2):71-6
19238511
Expert Opin Biol Ther. 2010 Feb;10(2):289-98
20088719
J Headache Pain. 2010 Oct;11(5):373-7
20473701
Lancet. 2010 Nov 27;376(9755):1825-6; discussion 1826
21111904
Expert Rev Neurother. 2010 Mar;10(3):339-40
20187855
Intern Emerg Med. 2010 Oct;5 Suppl 1:S13-9
20865469
Intern Emerg Med. 2009 Oct;4(5):367-73
19551474